Clinical trial
Dexmedetomidine During Carotid Endarterectomy: a Registry on Safety and Satisfaction of Patients and Operators (DexTEA)
NCT07105527 is registered in ClinicalTrials.gov with Saint Camillus International University of Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexmedetomidine During Carotid Endarterectomy: a Registry on Safety and Satisfaction of Patients and Operators (DexTEA)
- Lead sponsor
- Saint Camillus International University of Health Sciences
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 8, 2021
- Completion date
- August 2, 2023
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bradycardia, desaturation, dexmedetomidine induced sedation, fentanyl analgesia, hypertension arterial, hypotension during surgery, nausea/vomiting, satisfaction, patient, satisfaction, personal, surgery (major vascular)